MAPT and Alzheimer disease: The validated single‐output and multi‐output DL models achieved exceptional specificity and acceptable sensitivity compared to an exaggerated baseline, thereby abundantly demonstrating the proof of concept of learning and transferring amyloid or tau pathology models to detect and predict future risk of AD progression.